2-Me-DET

2-Me-DET
Clinical data
Other names3-(2-(Diethylamino)ethyl)-2-methylindole; 5-22-10-00158 (Beilstein Handbook Reference); BRN 0166959; Indole, 3-(2-(diethylamino)ethyl)-2-methyl-
Identifiers
  • N,N-diethyl-2-(2-methyl-1H-indol-3-yl)ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H22N2
Molar mass230.355 g·mol−1
3D model (JSmol)
  • CCN(CC)CCc1c(C)[nH]c2ccccc12
  • InChI=1S/C15H22N2/c1-4-17(5-2)11-10-13-12(3)16-15-9-7-6-8-14(13)15/h6-9,16H,4-5,10-11H2,1-3H3
  • Key:VVUATPWGKMGHGM-UHFFFAOYSA-N

2-Me-DET, or 2-methyl-diethyltryptamine, is a lesser-known psychedelic drug. It is the 2-methyl analog of DET. 2-Me-DET was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), the minimum dosage is listed as 80-120 mg, and the duration listed as 6–8 hours. 2-Me-DET produces pitch distortion, like that of DiPT. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2-Me-DET.

See also


Stub icon

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.